rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2005-12-26
|
pubmed:abstractText |
The synthesis and anti-Helicobacter pylori (H. pylori) activity evaluation of a new series of erythromycin A (E)-9-oxime ether derivatives are described. These compounds exhibited comparable in vitro anti-H. pylori activity and improved acid stability compared to the reference compound clarithromycin.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0960-894X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
569-72
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16275089-Anti-Bacterial Agents,
pubmed-meshheading:16275089-Chromatography, High Pressure Liquid,
pubmed-meshheading:16275089-Clarithromycin,
pubmed-meshheading:16275089-Drug Design,
pubmed-meshheading:16275089-Erythromycin,
pubmed-meshheading:16275089-Ethers,
pubmed-meshheading:16275089-Gastrointestinal Agents,
pubmed-meshheading:16275089-Helicobacter Infections,
pubmed-meshheading:16275089-Helicobacter pylori,
pubmed-meshheading:16275089-Humans,
pubmed-meshheading:16275089-Microbial Sensitivity Tests,
pubmed-meshheading:16275089-Models, Chemical,
pubmed-meshheading:16275089-Oximes
|
pubmed:year |
2006
|
pubmed:articleTitle |
Design, synthesis, and anti-Helicobacter pylori activity of erythromycin A (E)-9-oxime ether derivatives.
|
pubmed:affiliation |
Biochemicals Research Center, Korea Institute of Science and Technology, PO Box 131, Cheongryang, Seoul, Republic of Korea.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|